Reviva Pharmaceuticals to Present at the Lytham Partners Fall 2022 Investor Conference

September 26, 2022

https://www.globenewswire.com/news-release/2022/09/26/2522286/0/en/Reviva-Pharmaceuticals-to-Present-at-the-Lytham-Partners-Fall-2022-Investor-Conference.html

CUPERTINO, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Lytham Partners Fall 2022 Investor Conference being held September 28–29, 2022 and invites investors to participate via virtual one-on-one meetings. Please see additional details below:

Read more at globenewswire.com

Related news for (RVPH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.